​Not all states allow nurse practitioners to make a patient’s treatment wishes part of their medical record, yet a six-year study concludes that they can improve seriously ill patients’ access to advance-care planning. Nurse practitioners often serve as the primary care provider or a member of the team caring for patients in the last months of their lives when they are most likely to seek end-of-life treatment counseling.

Today OHSU announced Mark B. Williams has accepted the role of chief strategy officer for the OHSU Knight Cancer Institute. This is a new position focused on overseeing the budget and long-term financial sustainability of the Knight Cancer Institute.

Seventh annual Night for Networking features more than 50 employers committed to workforce diversity

CALENDAR ALERT: The Director of the National Institutes of Health, Francis S. Collins, M.D., Ph.D., will give this year’s Mark O. Hatfield Lecture.

For 11 years, TTBD has hosted an award ceremony to celebrate university accomplishments and recognize OHSU employees who’ve made significant contributions to innovation, entrepreneurship, industry partnership, patenting, and technology commercialization. Following are highlights from last night’s 2016 TTBD Awards Ceremony.

New research conducted at the OHSU Center for Policy and Research in Emergency Medicine uncovered disparities in timely access to emergency trauma care in rural versus urban communities.

Thanks to a $9.9 million grant from the National Heart, Lung, and Blood Institute, a team led by Markus Grompe, M.D., director of the Oregon Stem Cell Center at OHSU and the Papé Family Pediatric Research Institute at OHSU Doernbecher Children’s Hospital, will work to understand human response to novel drug treatments that have shown promise in FA-positive animal models.

OHSU leaders, faculty, staff and students gathered in the late afternoon rain outside Mackenzie Hall to mark an institution-wide commitment to address gun violence as a public health issue.

In a new study published online today in The Journal of Neuroscience, researchers found that chronic administration of estradiol boosts cognitive performance in aged female rhesus monkeys.

A drug that blocks the chemical messengers that are overactive in allergic reactions proved effective in clearing or reducing symptoms caused by atopic eczema, based on results from an international Phase III clinical trial led by OHSU in Portland, Oregon.